Uncategorized

GLP-1s can cut the risk of Alzheimer’s. What does that mean for Novo Nordisk? – Endpoints News

  1. GLP-1s can cut the risk of Alzheimer’s. What does that mean for Novo Nordisk?  Endpoints News
  2. Obesity drugs: huge study identifies new health risks  Nature.com
  3. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  4. Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds  CNN
  5. Sweeping review suggests weight-loss drugs’ effect on 175 conditions  The Washington Post